| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.006 |